Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70090 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Eun-Seok Shin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea. Hauptthemen laut MEDLINE: Coronary Artery Disease, Drug-Eluting Stents, Coated Materials, Biocompatible, Angioplasty, Balloon, Coronary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Drug‐coated balloon (DCB) treatment has shown outcomes comparable to drug‐eluting stent (DES) in small vessel coronary disease. However, evidence for its application in large vessel coronary artery disease (CAD) remains limited.
Aims
This study evaluated the clinical impact of DCB‐based percutaneous coronary intervention (PCI) in patients with large vessel CAD.
Methods
We retrospectively enrolled 550 consecutive patients with reference vessel diameter ≥ 3.0 mm treated with DCB‐based PCI and propensity‐matched them 1:1 to 550 patients who underwent conventional PCI with second‐generation DES (DES‐only group). The primary endpoint was 2‐year major adverse cardiac events (MACE), defined as a composite of cardiac death, non‐fatal myocardial infarction, definite target lesion thrombosis, and target vessel revascularization (TVR).
Results
In the DCB‐based group, 390 patients (70.9%) were treated with DCB alone. Total device length was higher in the DCB group (40.0 ± 23.3 vs. 35.4 ± 23.3 mm; p = 0.001), whereas mean implanted stent length was shorter (9.6 ± 18.4 vs. 35.4 ± 23.3 mm; p < 0.001). The cumulative 2‐year incidence of MACE was significantly lower after DCB‐based PCI than after DES‐only PCI (4.3% vs. 9.7%; hazard ratio: 0.43; 95% confidence interval: 0.26 to 0.70; p = 0.001). TVR was also lower in DCB‐based PCI (3.4% vs. 7.5%; hazard ratio: 0.45; 95% confidence interval: 0.25 to 0.81; p = 0.008). There was no difference in cardiac death, myocardial infarction, or major bleeding.
Conclusion
In patients with large vessel CAD, DCB‐based PCI strategy was associated with a significant reduction in MACE compared with DES‐only PCI at 2‐year follow‐up, primarily driven by a lower rate of TVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
- Department of Internal Medicine, Cardiovascular Center, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, South Korea.
- Department of Internal Medicine, Cardiovascular Center, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea.
- Department of Internal Medicine, Division of Cardiology, Kangwon National University College of Medicine, Kangwon National University School of Medicine, Chuncheon, South Korea.
- Department of Cardiology, Ulsan Medical Center, Ulsan, South Korea.
ORCID-Profile: Eun-Seok Shin
Zitieren
APA
Shin, E. S., Jang, M. H., Kim, S., Kang, D. O., Her, A. Y., & Sohn, C. B. (2025). Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70090
Vancouver
Shin ES, Jang MH, Kim S, Kang DO, Her AY, Sohn CB. Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70090
BibTeX
@article{Shin2025,
author = {Shin, Eun-Seok and Jang, Mi Hee and Kim, Sunwon and Kang, Dong Oh and Her, Ae-Young and Sohn, Chang-Bae},
title = {Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70090}
}
EUVIMED